Literature DB >> 16761618

Analysis of intrahepatic lymphocyte subsets in a transgenic mouse model of immune-mediated hepatocarcinogenesis.

Y Nakamoto1, S Kaneko.   

Abstract

Long-term, persistent liver cell injury increases the risk for hepatocellular carcinoma (HCC) development in chronic viral hepatitis. In support of this notion, we have developed a unique animal model of chronic immune-mediated liver disease that induces hepatocellular carcinogenesis using HBV transgenic mice; however, the intrahepatic inflammatory response was not precisely evaluated. The current study demonstrated that hepatitis B surface antigen (HBsAg)-specific cytotoxic T lymphocytes (CTLs) were detected at a frequency of 0.05% of CD8+ T lymphocytes in the liver, and that monocytes/macrophages were remarkably increased as the disease developed. These results suggest that a minimal number of intrahepatic virus-specific CTLs and the recruited monocytes/macrophages may contribute to the process of chronic liver inflammation.

Entities:  

Mesh:

Year:  2006        PMID: 16761618

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


  3 in total

1.  Inclusion of the bovine neutrophil beta-defensin 3 with glycoprotein D of bovine herpesvirus 1 in a DNA vaccine modulates immune responses of mice and cattle.

Authors:  Sarah Mackenzie-Dyck; Jennifer Kovacs-Nolan; Marlene Snider; Lorne A Babiuk; Sylvia van Drunen Littel-van den Hurk
Journal:  Clin Vaccine Immunol       Date:  2014-01-22

2.  Dynamic changes of cytotoxic T lymphocytes (CTLs), natural killer (NK) cells, and natural killer T (NKT) cells in patients with acute hepatitis B infection.

Authors:  Jun Li; Yaping Han; Ke Jin; Yufeng Wan; Shixia Wang; Bo Liu; Yuan Liu; Shan Lu; Zuhu Huang
Journal:  Virol J       Date:  2011-05-02       Impact factor: 4.099

Review 3.  Emerging role of dual antiplatelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma.

Authors:  Roberto Aiolfi; Giovanni Sitia
Journal:  J Hepatocell Carcinoma       Date:  2014-11-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.